Table 1.

Prevalance of P. falciparum development in An. stephensi mosquitoes

Treatment	Ookinete	Oocyst	Sporozoite
Normal human serum	83%	90%	53%
	(6)	(50)	(15)
Naive mouse serum	62%	59%*	44%
	(8)	(51)	(32)
Anti-mosquito midgut serum	62%	2%**	4%**
	(8)	(50)	(23)

Infection prevalence is expressed as percentages of infected mosquitoes per total examined (number of mosquitoes examined). Statistical comparisons were made within each lifestage among the three treatments. Treatments that have a single asterisk are significantly different from the normal human serum control at the 0.05 level of significance. Treatments with double asterisks are significantly different from both the normal human serum control and the naive mouse serum groups at the 0.05 level of significance.